deltatrials
Terminated PHASE2 NCT02485834

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

Impact of Early FDG-PET Directed Intervention on Preoperative Therapy for Locally Advanced Gastric Cancer: A Random Assignment Phase II Study

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Adenocarcinoma of the Gastroesophageal Junction Gastric Adenocarcinoma Gastric Cancer
Interventions 3D-CRT 5-FU FDG-PET IMRT Irinotecan capecitabine docetaxel surgery
Updated 14 times since 2017 Last updated: Jan 9, 2025 Started: Nov 12, 2015 Primary completion: Aug 1, 2018 Completion: Aug 1, 2018

A PHASE2 clinical study on Adenocarcinoma of the Gastroesophageal Junction and Gastric Adenocarcinoma, this trial is terminated or withdrawn. The trial is conducted by Alliance for Clinical Trials in Oncology and has accumulated 14 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Feb 2025 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Sep 2024 — Feb 2025 [monthly]

    Terminated PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  5. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

▶ Show 9 earlier versions

  1. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  2. Jan 2021 — Dec 2022 [monthly]

    Terminated PHASE2

  3. Oct 2019 — Jan 2021 [monthly]

    Terminated PHASE2

  4. Feb 2019 — Oct 2019 [monthly]

    Terminated PHASE2

    Status: Active Not Recruiting → Terminated

  5. Jun 2018 — Feb 2019 [monthly]

    Active Not Recruiting PHASE2

  6. Jul 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  7. May 2017 — Jul 2017 [monthly]

    Recruiting PHASE2

  8. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE2

  9. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alliance for Clinical Trials in Oncology
  • National Cancer Institute (NCI)
Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States, Ann Arbor, United States, Atlanta, United States, Basking Ridge, United States, Billings, United States, Boston, United States, Bozeman, United States, Burlington, United States, Butte, United States, Charleston, United States and 37 more location s